Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,654 | -10,201 | -6,966 | -3,325 | -13,654 |
| Depreciation Amortization | 19 | 16 | 11 | 5 | 20 |
| Other Working Capital | -2,407 | -1,447 | -1,416 | -1,271 | 901 |
| Other Operating Activity | 804 | 627 | 427 | 192 | 806 |
| Operating Cash Flow | $-15,238 | $-11,005 | $-7,944 | $-4,399 | $-11,927 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,512 | -11,113 | -11,402 | -12,610 | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -13 |
| Investing Cash Flow | $-8,512 | $-11,113 | $-11,402 | $-12,610 | $-13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 9,194 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $9,194 |
| Beginning Cash Position | 27,285 | 27,285 | 27,285 | 30,031 | 30,031 |
| End Cash Position | 3,535 | 5,167 | 7,939 | 13,022 | 27,285 |
| Net Cash Flow | $-23,750 | $-22,118 | $-19,346 | $-17,009 | $-2,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,238 | -11,005 | -7,944 | -4,399 | -11,927 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -13 |
| Free Cash Flow | -15,238 | -11,005 | -7,944 | -4,399 | -11,940 |